Logo image of NXP

NUVEEN SELECT TAX-FREE INC (NXP) Stock Price, Quote, News and Overview

NYSE:NXP - New York Stock Exchange, Inc. - US67062F1003 - Currency: USD

14.07  +0.11 (+0.79%)

After market: 14.1 +0.03 (+0.21%)

Fundamental Rating

3

Overall NXP gets a fundamental rating of 3 out of 10. We evaluated NXP against 0 industry peers in the Unkown industry. Both the profitability and financial health of NXP have multiple concerns. NXP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NXP had positive earnings in the past year.
In multiple years NXP reported negative net income over the last 5 years.
In the past 5 years NXP always reported negative operating cash flow.
NXP Yearly Net Income VS EBIT VS OCF VS FCFNXP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

Industry RankSector Rank
ROA 11.28%
ROE 11.52%
ROIC 3.62%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NXP Yearly ROA, ROE, ROICNXP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 6 -6

1.3 Margins

NXP's Profit Margin has declined in the last couple of years.
NXP's Operating Margin has been stable in the last couple of years.
NXP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 96.77%
PM (TTM) 241.94%
GM 95.35%
OM growth 3Y1.18%
OM growth 5Y0.68%
PM growth 3Y-16.4%
PM growth 5Y-7.52%
GM growth 3Y0.36%
GM growth 5Y0.21%
NXP Yearly Profit, Operating, Gross MarginsNXP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

NXP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NXP Yearly Shares OutstandingNXP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
NXP Yearly Total Debt VS Total AssetsNXP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

NXP has an Altman-Z score of 29.60. This indicates that NXP is financially healthy and has little risk of bankruptcy at the moment.
NXP has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 29.6
ROIC/WACCN/A
WACCN/A
NXP Yearly LT Debt VS Equity VS FCFNXP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.3 Liquidity

NXP has a Current Ratio of 1.05. This is a normal value and indicates that NXP is financially healthy and should not expect problems in meeting its short term obligations.
NXP has a Quick Ratio of 1.05. This is a normal value and indicates that NXP is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
NXP Yearly Current Assets VS Current LiabilitesNXP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

4

3. Growth

3.1 Past

NXP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 196.15%, which is quite impressive.
Measured over the past years, NXP shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.91% on average per year.
The Revenue has been growing slightly by 5.60% in the past year.
The Revenue has been growing by 24.33% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)196.15%
EPS 3Y-16.49%
EPS 5Y-6.91%
EPS Q2Q%182%
Revenue 1Y (TTM)5.6%
Revenue growth 3Y42.05%
Revenue growth 5Y24.33%
Sales Q2Q%7.94%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NXP Yearly Revenue VS EstimatesNXP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.14, the valuation of NXP can be described as reasonable.
When comparing the Price/Earnings ratio of NXP to the average of the S&P500 Index (26.25), we can say NXP is valued rather cheaply.
Industry RankSector Rank
PE 9.14
Fwd PE N/A
NXP Price Earnings VS Forward Price EarningsNXP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXP Per share dataNXP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.09%, NXP is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.40, NXP pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.09%

5.2 History

NXP has paid a dividend for at least 10 years, which is a reliable track record.
As NXP did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years7
NXP Yearly Dividends per shareNXP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
NXP Yearly Income VS Free CF VS DividendNXP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

More info and screens

NUVEEN SELECT TAX-FREE INC

NYSE:NXP (5/30/2025, 8:21:28 PM)

After market: 14.1 +0.03 (+0.21%)

14.07

+0.11 (+0.79%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)12-02 2024-12-02
Earnings (Next)N/A N/A
Inst Owners17.31%
Inst Owner Change-2.03%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap691.96M
Analysts45
Price TargetN/A
Short Float %0.08%
Short Ratio0.33
Dividend
Industry RankSector Rank
Dividend Yield 4.09%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years7
Ex-Date05-15 2025-05-15 (0.052)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.14
Fwd PE N/A
P/S 22.32
P/FCF N/A
P/OCF N/A
P/B 1.06
P/tB 1.06
EV/EBITDA N/A
EPS(TTM)1.54
EY10.95%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.63
BVpS13.24
TBVpS13.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.28%
ROE 11.52%
ROCE 4.58%
ROIC 3.62%
ROICexc 3.62%
ROICexgc 3.62%
OM 96.77%
PM (TTM) 241.94%
GM 95.35%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y1.18%
OM growth 5Y0.68%
PM growth 3Y-16.4%
PM growth 5Y-7.52%
GM growth 3Y0.36%
GM growth 5Y0.21%
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 29.6
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)196.15%
EPS 3Y-16.49%
EPS 5Y-6.91%
EPS Q2Q%182%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.6%
Revenue growth 3Y42.05%
Revenue growth 5Y24.33%
Sales Q2Q%7.94%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.14%
EBIT growth 3Y43.71%
EBIT growth 5Y25.17%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A